<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: A Pivotal Phase II/III Clinical Study of Anti-HER2 Bispecific Antibody KN026 Have Met the Primary Endpoint of PFS at Interim Analysis	</title>
	<atom:link href="https://9krapalm.com/a-pivotal-phase-ii-iii-clinical-study-of-anti-her2-bispecific-antibody-kn026-have-met-the-primary-endpoint-of-pfs-at-interim-analysis/feed/" rel="self" type="application/rss+xml" />
	<link>https://9krapalm.com/a-pivotal-phase-ii-iii-clinical-study-of-anti-her2-bispecific-antibody-kn026-have-met-the-primary-endpoint-of-pfs-at-interim-analysis/</link>
	<description>เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm</description>
	<lastBuildDate>Thu, 01 May 2025 02:49:47 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.1</generator>
</channel>
</rss>
